{
    "2020-05-06": [
        [
            {
                "time": "",
                "original_text": "险资口味有变！调研行踪显示，这只创业板白马股最热门，医药医疗股关注度提升",
                "features": {
                    "keywords": [
                        "险资",
                        "口味变化",
                        "调研",
                        "创业板",
                        "白马股",
                        "医药医疗股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗",
                        "创业板"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "津市监宝价案〔2020〕13号 其他违规处罚",
                "features": {
                    "keywords": [
                        "违规处罚",
                        "市场监管"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【兴证医药】行业比较优势突出，细分领域分化明显 — 医药生物上市公司2019年报及2020年一季报小结",
                "features": {
                    "keywords": [
                        "兴证医药",
                        "行业比较",
                        "细分领域",
                        "医药生物",
                        "年报",
                        "季报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "短期调整VS行业比较优势——兴证医药2020年5月投资月报",
                "features": {
                    "keywords": [
                        "短期调整",
                        "行业比较",
                        "兴证医药",
                        "投资月报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【中信建投医药|年报及季报综述】5月关注“疫情后修复”与“新基建”",
                "features": {
                    "keywords": [
                        "中信建投医药",
                        "年报",
                        "季报",
                        "疫情后修复",
                        "新基建"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "36氪首发 | 瞄准年轻用户的口腔护理市场，「BOP」获BAI领投千万元Pre-A轮融资",
                "features": {
                    "keywords": [
                        "36氪",
                        "口腔护理",
                        "BOP",
                        "融资",
                        "Pre-A轮"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "口腔护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}